Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
5.84
-0.07 (-1.18%)
Jul 13, 2026, 4:00 PM EDT - Market closed
Decoy Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
3.11M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 1.84M | -3.39M | -64.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionDCOY News
- 3 days ago - Decoy Therapeutics registers to sell 3.77M shares of common stock for holders - TheFly
- 3 days ago - Decoy Therapeutics Registration statement: Registration filing - Filings
- 14 days ago - Why Is Penny Stock Decoy Therapeutics (DCOY) Up Today? - TipRanks
- 14 days ago - Decoy Therapeutics Inc trading resumes - TheFly
- 14 days ago - Decoy Therapeutics Inc trading halted, volatility trading pause - TheFly
- 17 days ago - Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing - PRNewsWire
- 4 weeks ago - Decoy Therapeutics Registration statement: Registration filing - Filings
- 4 weeks ago - Decoy Therapeutics files to sell 808,000 shares of common stock for holders - TheFly